Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial.

Cauley, JA; Black, D; Boonen, S; Cummings, SR; Mesenbrink, P; Palermo, L; Man, Z; Hadji, P; Reid, IR; HORIZON, Pivotal Fracture Group (2011). Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial. Journal of bone and mineral research, 26(5), pp. 984-992. Hoboken, N.J.: Wiley-Blackwell 10.1002/jbmr.292

Full text not available from this repository.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Orthopaedic, Plastic and Hand Surgery (DOPH) > Clinic of Osteoporosis

UniBE Contributor:

Lippuner, Kurt

ISSN:

0884-0431

Publisher:

Wiley-Blackwell

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:23

Last Modified:

05 Dec 2022 14:06

Publisher DOI:

10.1002/jbmr.292

Web of Science ID:

000290486800011

URI:

https://boris.unibe.ch/id/eprint/8084 (FactScience: 213550)

Actions (login required)

Edit item Edit item
Provide Feedback